论文部分内容阅读
探讨不完全血运重建联合CRT-P治疗老年缺血性心肌病的临床疗效.通过选取90例老年缺血性心肌病患者并随机分为药物组、PCI组与联合组,每组30例.药物组单纯内科药物治疗,PCI组予冠脉介入不完全血运重建治疗,联合组患者不完全血运重建联合CRT-P心脏再同步化治疗.结果表明,联合治疗组患者心功能改善较药物组、PCI组患者明显.差异有统计学意义(P<0.05).研究表明,对老年缺血性心肌病患者采取不完全血运重建联合CRT-P治疗可显著改善患者心功能,不增加心血管事件风险.不完全血运重建联合CRT-P对治疗老年缺血性心肌病具有重要临床意义.
To investigate the clinical efficacy of incomplete revascularization combined with CRT-P in the treatment of senile ischemic cardiomyopathy.Methods Ninety elderly patients with ischemic cardiomyopathy were selected and randomly divided into drug group, PCI group and combination group, with 30 cases in each group. PCI group was treated with incomplete coronary revascularization and incomplete revascularization combined with CRT-P cardiac resynchronization therapy in the drug group.The results showed that the cardiac function in patients in combination group was better than that in drug group (P <0.05) .Studies show that taking incomplete revascularization combined with CRT-P in elderly patients with ischemic cardiomyopathy can significantly improve the patient’s cardiac function, do not increase the heart Vascular event risk. Incomplete revascularization combined with CRT-P has important clinical significance in the treatment of elderly ischemic cardiomyopathy.